What’s the current market cap for Walker & Dunlop stock?

Walker & Dunlop (WD) has a market cap of $1.8bn as of June 08, 2026.

What is the P/E ratio for Walker & Dunlop stock?

The price to earnings (P/E) ratio for Walker & Dunlop (WD) stock is 25.38 as of June 08, 2026.

Does Walker & Dunlop stock pay dividends?

Yes, the Walker & Dunlop (WD) stock pays dividends to shareholders. As of June 08, 2026, the dividend rate is $2.7 and the yield is 5.31%. Walker & Dunlop has a payout ratio of 131.72% on a trailing twelve-month basis.

When is the next Walker & Dunlop dividend payment date?

The next Walker & Dunlop (WD) dividend payment date is unconfirmed.

What is the beta indicator for Walker & Dunlop?

Walker & Dunlop (WD) has a beta rating of 1.51. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy Walker & Dunlop stock | $WD Share Price

About Walker & Dunlop

Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of its total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.

Ticker

$WD

Sector

Finance

Primary listing

NYSE

Employees

1,466

Headquarters

Bethesda, United States

Website

www.walkerdunlop.com

Walker & Dunlop Metrics

BasicAdvanced

$1.8bn

25.38

$2.02

1.51

$2.70

5.31%

What the Analysts think about Walker & Dunlop

Analyst ratings (Buy, Hold, Sell) for Walker & Dunlop stock.

Bulls say / Bears say

Total transaction volume rose 94% year-over-year to $13.7 billion in Q1 2026, signaling a strong rebound in commercial real estate financing activity (Investing.com).

Net income reached $15.9 million and diluted EPS came in at $0.46 in Q1 2026, up 476% and 475% year-over-year, reflecting strong growth in mortgage banking revenues (Business Wire).

The servicing portfolio increased 8% to $146.4 billion as of March 31, 2026, supporting higher recurring fee income and showing resilience in credit fundamentals (Nasdaq).

Q4 2025 earnings were impacted by substantial one-time charges of $20.1 million related to indemnified and repurchased loan expenses and asset impairments, reducing profitability despite higher transaction volumes (Investing.com).

Walker & Dunlop reported adjusted EPS of $0.28 in Q4 2025, falling short of analyst expectations of $1.23 by $0.95 (−77.2%), indicating significant earnings volatility (Investing.com).

Loan repurchase losses of $6.95 million in Q1 2026, as shown in the company’s adjusted EBITDA reconciliation, highlight persistent expenses tied to indemnified loan commitments (Investor Presentation).

Data summarised monthly by Lightyear AI. Last updated on 23 May 2026.

Walker & Dunlop Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

Walker & Dunlop Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Walker & Dunlop News

AllArticlesVideos

Walker & Dunlop Arranges $223 Million Bridge Financing for Multifamily Portfolio

Business Wire·4 days ago

Walker & Dunlop Arranges $128.5 Million Financing for The Arno in Houston's River Oaks

Business Wire·3 weeks ago

Walker & Dunlop Arranges Largest HUD 221(d)(4) in Company History; $130 Million for Former VA Hospital Redevelopment

Business Wire·4 weeks ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.